3.29.19
SWHR to Honor VA Executive, Neuroscience Researcher, and Former Board Chair at Annual Awards Dinner
The Society for Women’s Health Research will celebrate advancements and innovations in women’s health by honoring three leaders for their contributions to the field at SWHR’s 29th Annual Awards Dinner on May 1 at the InterContinental Washington DC – The Wharf.
3.25.19
Griffith, Ybarra Join SWHR Board of Directors
SWHR announced the election of two new members to its Board of Directors: Dr. Linda G. Griffith and Dr. Michael Ybarra.
3.11.19
Struggling to ‘Spring Forward’? Rethink Your Sleep Routine
Science is telling us more clearly all the time that we are setting ourselves up for failure by ignoring sleep as a critical part of the equation for good health.
3.4.19
The HPV Vaccine: A Step Forward for Women’s Health
The HPV vaccine is one of the major milestones in cancer research, displaying the great promise of cancer prevention.
2.27.19
Pregnancy Complications May Influence Women’s Future Heart Health
A growing body of evidence shows women may have an increased risk of heart disease in the decades following a pregnancy in which they suffered from complications such as gestational diabetes or preeclampsia.
2.25.19
Identifying Barriers to Care for Women With Endometriosis
An SWHR working group published an expert review that identifies areas of need to improve a woman’s diagnosis, treatment, and access to quality care, as well as highlights priorities for the future of endometriosis research and care.
1.22.19
New Treatments, Universal Screening May Ease Burden of Perinatal Depression
The most common, most underdiagnosed, and most undertreated pregnancy-related complication in the United States is perinatal depression — depression that occurs during pregnancy or within the first year after delivery. An estimated 10 to 20 percent of new mothers experience perinatal depression (a more inclusive term than postpartum depression), with half of these women going undiagnosed and untreated.
1.14.19
SWHR Engages With FDA on Patient-Focused Drug Development
SWHR seeks to ensure that meaningful input from women is included in the development and regulatory review of new medical products.
12.20.18
Roche Diagnostics CMO Alan Wright Joins SWHR Board of Directors
The Society for Women’s Health Research (SWHR) is pleased to announced the election of Alan Wright, MD, MPH, chief medical officer at Roche Diagnostics Corp., to its Board of Directors.
12.6.18
SWHR Praises Work of Dedicated FDA Women’s Health Advocate Marsha Henderson
In her 22 years at the Food and Drug Administration, Marsha B. Henderson has had a profound influence on the advancement of women’s health research. When she retires at the end of this year, the FDA will surely feel the absence of this dedicated advocate and her leadership as FDA’s associate commissioner for women’s health and director of the Office of Women’s Health (OWH).
